{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:07:12Z","timestamp":1792782432068,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation of Heilongjiang Province of China","award":["NO.PL2024H046"],"award-info":[{"award-number":["NO.PL2024H046"]}]},{"name":"the Young Scientists Fund of the National Natural Science Foundation of China","award":["No.82200905"],"award-info":[{"award-number":["No.82200905"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02369-5","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:58:46Z","timestamp":1790528326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interferon-mediated regulation of the neurovascular unit in diabetic retinopathy"],"prefix":"10.1007","volume":"75","author":[{"given":"Haoyang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"issue":"5","key":"2369_CR1","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4103\/1673-5374.355743","volume":"18","author":"L Tang","year":"2022","unstructured":"Tang L, Xu GT, Zhang JF. Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy. Neural Regen Res. 2022;18(5):976\u201382. https:\/\/doi.org\/10.4103\/1673-5374.355743.","journal-title":"Neural Regen Res"},{"key":"2369_CR2","doi-asserted-by":"publisher","unstructured":"Pushparani DS, Varalakshmi J, Roobini K, et al. Diabetic retinopathy-a review. Curr Diabetes Rev. 2025. https:\/\/doi.org\/10.2174\/0115733998296228240521151050.","DOI":"10.2174\/0115733998296228240521151050"},{"key":"2369_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.freeradbiomed.2025.03.050","volume":"233","author":"L Yang","year":"2025","unstructured":"Yang L, Yao Y, Zheng W, et al. Nitric oxide mediates negative feedback on the TXNIP\/NLRP3 inflammasome pathway to prevent retinal neurovascular unit dysfunction in early diabetic retinopathy. Free Radic Biol Med. 2025;233:279\u201391. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.03.050.","journal-title":"Free Radic Biol Med"},{"key":"2369_CR4","doi-asserted-by":"publisher","DOI":"10.3410\/B2-3","volume":"2","author":"R Zhou","year":"2010","unstructured":"Zhou R, Caspi RR. Ocular immune privilege. F1000 Biol Rep. 2010;2:3. https:\/\/doi.org\/10.3410\/B2-3.","journal-title":"F1000 Biol Rep"},{"issue":"9","key":"2369_CR5","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1007\/s00125-018-4692-1","volume":"61","author":"R Sim\u00f3","year":"2018","unstructured":"Sim\u00f3 R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. 2018;61(9):1902\u201312. https:\/\/doi.org\/10.1007\/s00125-018-4692-1.","journal-title":"Diabetologia"},{"issue":"10","key":"2369_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108796","volume":"24","author":"H Ramos","year":"2023","unstructured":"Ramos H, Hern\u00e1ndez C, Sim\u00f3 R, et al. Inflammation: the link between neural and vascular impairment in the diabetic retina and therapeutic implications. Int J Mol Sci. 2023;24(10):8796. https:\/\/doi.org\/10.3390\/ijms24108796.","journal-title":"Int J Mol Sci"},{"key":"2369_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1724908","volume":"16","author":"Q Yao","year":"2025","unstructured":"Yao Q, Chen S, Qian W, et al. Role and mechanism of gut microbiota in regulating interferon-mediated programmed cell death in colorectal cancer. Front Immunol. 2025;16:1724908. https:\/\/doi.org\/10.3389\/fimmu.2025.1724908.","journal-title":"Front Immunol"},{"issue":"7","key":"2369_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4239\/wjd.v12.i7.939","volume":"12","author":"BY Li","year":"2021","unstructured":"Li BY, Tan W, Zou JL, et al. Role of interferons in diabetic retinopathy. World J Diabetes. 2021;12(7):939\u201353. https:\/\/doi.org\/10.4239\/wjd.v12.i7.939.","journal-title":"World J Diabetes"},{"issue":"5","key":"2369_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cells14050376","volume":"14","author":"H Seo","year":"2025","unstructured":"Seo H, Park SJ, Song M. Diabetic retinopathy (DR): mechanisms, current therapies, and emerging strategies. Cells. 2025;14(5):376. https:\/\/doi.org\/10.3390\/cells14050376.","journal-title":"Cells"},{"issue":"24","key":"2369_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262411984","volume":"26","author":"Z Chen","year":"2025","unstructured":"Chen Z, Jin Q, Li J, et al. When mitochondria falter, the barrier fails: mechanisms of inner blood-retinal barrier (iBRB) injury and opportunities for mitochondria-targeted repair. Int J Mol Sci. 2025;26(24):11984. https:\/\/doi.org\/10.3390\/ijms262411984.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2369_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cells14120856","volume":"14","author":"F Moccia","year":"2025","unstructured":"Moccia F, Dragoni S. The calcium signalling profile of the inner blood-retinal barrier in diabetic retinopathy. Cells. 2025;14(12):856. https:\/\/doi.org\/10.3390\/cells14120856.","journal-title":"Cells"},{"issue":"3","key":"2369_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030458","volume":"10","author":"M Mrugacz","year":"2021","unstructured":"Mrugacz M, Bryl A, Zorena K. Retinal vascular endothelial cell dysfunction and neuroretinal degeneration in diabetic patients. J Clin Med. 2021;10(3):458. https:\/\/doi.org\/10.3390\/jcm10030458.","journal-title":"J Clin Med"},{"key":"2369_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.953691","volume":"13","author":"J Ren","year":"2022","unstructured":"Ren J, Zhang S, Pan Y, et al. Diabetic retinopathy: involved cells, biomarkers, and treatments. Front Pharmacol. 2022;13:953691. https:\/\/doi.org\/10.3389\/fphar.2022.953691.","journal-title":"Front Pharmacol"},{"issue":"2","key":"2369_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/glia.23542","volume":"67","author":"DH Jo","year":"2019","unstructured":"Jo DH, Yun JH, Cho CS, et al. Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy. Glia. 2019;67(2):321\u201331. https:\/\/doi.org\/10.1002\/glia.23542.","journal-title":"Glia"},{"issue":"8","key":"2369_CR15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/1535370220976073","volume":"246","author":"JX Wang","year":"2021","unstructured":"Wang JX, Yang Y, Li WY. SIRT3 deficiency increases mitochondrial oxidative stress and promotes migration of retinal pigment epithelial cells. Exp Biol Med (Maywood). 2021;246(8):877\u201387. https:\/\/doi.org\/10.1177\/1535370220976073.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"2369_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-025-01226-7","volume":"38","author":"T Lu","year":"2025","unstructured":"Lu T, Shang J, Pu S, et al. The role of microglia in the development of diabetic retinopathy and its potential clinical application. Hum Cell. 2025;38(4):101. https:\/\/doi.org\/10.1007\/s13577-025-01226-7.","journal-title":"Hum Cell"},{"key":"2369_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1276225","volume":"14","author":"Y Yao","year":"2023","unstructured":"Yao Y, Li J, Zhou Y, et al. Macrophage\/microglia polarization for the treatment of diabetic retinopathy. Front Endocrinol. 2023;14:1276225. https:\/\/doi.org\/10.3389\/fendo.2023.1276225.","journal-title":"Front Endocrinol"},{"issue":"12","key":"2369_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10121948","volume":"10","author":"EYC Kang","year":"2021","unstructured":"Kang EYC, Liu PK, Wen YT, et al. Role of oxidative stress in ocular diseases associated with retinal ganglion cells degeneration. Antioxidants (Basel). 2021;10(12):1948. https:\/\/doi.org\/10.3390\/antiox10121948.","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"2369_CR19","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1111\/j.1471-4159.2010.07057.x","volume":"115","author":"Y Munemasa","year":"2010","unstructured":"Munemasa Y, Kitaoka Y, Kuribayashi J, et al. Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model. J Neurochem. 2010;115(6):1508\u201319. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07057.x.","journal-title":"J Neurochem"},{"key":"2369_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/joph\/3278794","volume":"2025","author":"J Mu","year":"2025","unstructured":"Mu J, Zhang Z, Jiang C, et al. Role of tau protein hyperphosphorylation in diabetic retinal neurodegeneration. J Ophthalmol. 2025;2025:3278794. https:\/\/doi.org\/10.1155\/joph\/3278794.","journal-title":"J Ophthalmol"},{"issue":"4","key":"2369_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/ceo.12724","volume":"44","author":"DS Ng","year":"2016","unstructured":"Ng DS, Chiang PP, Tan G, et al. Retinal ganglion cell neuronal damage in diabetes and diabetic retinopathy. Clin Exp Ophthalmol. 2016;44(4):243\u201350. https:\/\/doi.org\/10.1111\/ceo.12724.","journal-title":"Clin Exp Ophthalmol"},{"key":"2369_CR22","doi-asserted-by":"publisher","unstructured":"Minagar A, Long A, Ma T, et al. Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier[J\/OL]. Endothelium: Journal of Endothelial Cell Research, 2003, 10(6): 299\u2013307. https:\/\/doi.org\/10.1080\/10623320390272299.","DOI":"10.1080\/10623320390272299"},{"issue":"5","key":"2369_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/jir.2018.0125","volume":"39","author":"N Lewczuk","year":"2019","unstructured":"Lewczuk N, Zdebik A, Bogus\u0142awska J. Interferon alpha 2a and 2b in ophthalmology: a review. J Interferon Cytokine Res. 2019;39(5):259\u201372. https:\/\/doi.org\/10.1089\/jir.2018.0125.","journal-title":"J Interferon Cytokine Res"},{"issue":"s1","key":"2369_CR24","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.3233\/JAD-221081","volume":"94","author":"BSM Hui","year":"2023","unstructured":"Hui BSM, Zhi LR, Retinasamy T, et al. The role of interferon-\u03b1 in neurodegenerative diseases: a systematic review[J\/OL]. J Alzheimer\u2019s Disease: JAD. 2023;94(s1):S45\u201366. https:\/\/doi.org\/10.3233\/JAD-221081.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"issue":"2","key":"2369_CR25","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00216-021-03702-z","volume":"414","author":"KC Januarie","year":"2022","unstructured":"Januarie KC, Uhuo OV, Iwuoha E, et al. Recent advances in the detection of interferon-gamma as a TB biomarker. Anal Bioanal Chem. 2022;414(2):907\u201321. https:\/\/doi.org\/10.1007\/s00216-021-03702-z.","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"2369_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005;5(5):375\u201386. https:\/\/doi.org\/10.1038\/nri1604.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2369_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.rdc.2021.04.001","volume":"47","author":"S Sirobhushanam","year":"2021","unstructured":"Sirobhushanam S, Lazar S, Kahlenberg JM. Interferons in systemic lupus erythematosus. Rheum Dis Clin North Am. 2021;47(3):297\u2013315. https:\/\/doi.org\/10.1016\/j.rdc.2021.04.001.","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"2369_CR28","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10616-014-9743-y","volume":"67","author":"W Li","year":"2015","unstructured":"Li W, Hao Q, He L, et al. Recombinant IFN-\u03b12a-NGR exhibits higher inhibitory function on tumor neovessels formation compared with IFN-\u03b12a in vivo and in vitro. Cytotechnology. 2015;67(6):1039\u201350. https:\/\/doi.org\/10.1007\/s10616-014-9743-y.","journal-title":"Cytotechnology"},{"issue":"3","key":"2369_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4049\/jimmunol.1801511","volume":"203","author":"E Papasavvas","year":"1950","unstructured":"Papasavvas E, Azzoni L, Kossenkov AV, et al. NK response correlates with HIV decrease in pegylated IFN-\u03b12a-treated antiretroviral therapy-suppressed subjects. J Immunol. 1950;203(3):705\u201317. https:\/\/doi.org\/10.4049\/jimmunol.1801511.","journal-title":"J Immunol"},{"issue":"10","key":"2369_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01280-25","volume":"99","author":"Y Ding","year":"2025","unstructured":"Ding Y, Li Q, Sha Y, et al. Multimodal characterization of the responsiveness of eight hepatitis D virus genotype isolates to interferon-alpha treatment. J Virol. 2025;99(10):e01280-25. https:\/\/doi.org\/10.1128\/jvi.01280-25.","journal-title":"J Virol"},{"issue":"1","key":"2369_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00415-y","volume":"10","author":"F Xiong","year":"2022","unstructured":"Xiong F, Wang Q, Wu GH, et al. Direct and indirect effects of IFN-\u03b12b in malignancy treatment: not only an archer but also an arrow. Biomark Res. 2022;10(1):69. https:\/\/doi.org\/10.1186\/s40364-022-00415-y.","journal-title":"Biomark Res"},{"issue":"1","key":"2369_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-025-00663-8","volume":"11","author":"S Karimi","year":"2025","unstructured":"Karimi S, Nouri M, Mansouri AR, et al. Interferon alpha-2b addition to intravitreal bevacizumab for diabetic macular edema: a randomized controlled trial. Int J Retina Vitreous. 2025;11(1):40. https:\/\/doi.org\/10.1186\/s40942-025-00663-8.","journal-title":"Int J Retina Vitreous"},{"issue":"4","key":"2369_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00005-017-0458-6","volume":"65","author":"N Lubina-D\u0105browska","year":"2017","unstructured":"Lubina-D\u0105browska N, Stepie\u0144 A, Sulkowski G, et al. Effects of IFN-\u03b21a and IFN-\u03b21b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis. Arch Immunol Ther Exp. 2017;65(4):325\u201338. https:\/\/doi.org\/10.1007\/s00005-017-0458-6.","journal-title":"Arch Immunol Ther Exp"},{"issue":"3","key":"2369_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4184\/asj.2016.10.3.407","volume":"10","author":"M\u00d6 Ta\u015fkapilio\u011flu","year":"2016","unstructured":"Ta\u015fkapilio\u011flu M\u00d6, I\u015fik S, Do\u011fan \u015e, et al. Effects of systemic and local interferon beta-1a on epidural fibrosis[J\/OL]. Asian Spine Journal. 2016;10(3):407\u201313. https:\/\/doi.org\/10.4184\/asj.2016.10.3.407.","journal-title":"Asian Spine Journal"},{"issue":"12","key":"2369_CR35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.168945","volume":"8","author":"H Liu","year":"2023","unstructured":"Liu H, Ghosh S, Vaidya T, et al. Activated cGAS\/STING signaling elicits endothelial cell senescence in early diabetic retinopathy. JCI Insight. 2023;8(12):e168945. https:\/\/doi.org\/10.1172\/jci.insight.168945.","journal-title":"JCI Insight"},{"key":"2369_CR36","first-page":"2931","volume":"16","author":"J Liu","year":"2010","unstructured":"Liu J, Shi B, He S, et al. Changes to tear cytokines of type 2 diabetic patients with or without retinopathy[J]. Mol Vis. 2010;16:2931\u20138.","journal-title":"Mol Vis"},{"issue":"2","key":"2369_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/08820538.2020.1755320","volume":"35","author":"K Cvitkovic","year":"2020","unstructured":"Cvitkovic K, Sesar A, Sesar I, et al. Concentrations of selected cytokines and vascular endothelial growth factor in aqueous humor and serum of diabetic patients. Semin Ophthalmol. 2020;35(2):126\u201333. https:\/\/doi.org\/10.1080\/08820538.2020.1755320.","journal-title":"Semin Ophthalmol"},{"key":"2369_CR38","first-page":"718","volume":"26","author":"NI Ucgun","year":"2020","unstructured":"Ucgun NI, Zeki-Fikret C, Yildirim Z. Inflammation and diabetic retinopathy[J]. Mol Vis. 2020;26:718\u201321.","journal-title":"Mol Vis"},{"issue":"6","key":"2369_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/jnci\/95.6.437","volume":"95","author":"Z VON Marschall","year":"2003","unstructured":"VON Marschall Z, Scholz A, Cramer T, et al. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. J Natl Cancer Inst. 2003;95(6):437\u201348. https:\/\/doi.org\/10.1093\/jnci\/95.6.437.","journal-title":"J Natl Cancer Inst"},{"issue":"4443","key":"2369_CR40","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.6154315","volume":"208","author":"D Brouty-Boy\u00e9","year":"1980","unstructured":"Brouty-Boy\u00e9 D, Zetter BR. Inhibition of cell motility by interferon. Sci (New York, NY). 1980;208(4443):516\u20138. https:\/\/doi.org\/10.1126\/science.6154315.","journal-title":"Sci (New York, NY)"},{"issue":"3","key":"2369_CR41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1006\/mvre.1995.1024","volume":"49","author":"MC Gillies","year":"1995","unstructured":"Gillies MC, Su T. Interferon-alpha 2b enhances barrier function of bovine retinal microvascular endothelium in vitro[J\/OL]. Microvasc Res. 1995;49(3):277\u201388. https:\/\/doi.org\/10.1006\/mvre.1995.1024.","journal-title":"Microvasc Res"},{"issue":"6","key":"2369_CR42","doi-asserted-by":"publisher","first-page":"670","DOI":"10.15252\/emmm.201505994","volume":"8","author":"A L\u00fcckoff","year":"2016","unstructured":"L\u00fcckoff A, Caramoy A, Scholz R, et al. Interferon-beta signaling in retinal mononuclear phagocytes attenuates pathological neovascularization. EMBO Mol Med. 2016;8(6):670\u20138. https:\/\/doi.org\/10.15252\/emmm.201505994.","journal-title":"EMBO Mol Med"},{"issue":"1\u20132","key":"2369_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0165-5728(02)00098-x","volume":"127","author":"S Floris","year":"2002","unstructured":"Floris S, Ruuls SR, Wierinckx A, et al. Interferon-beta directly influences monocyte infiltration into the central nervous system[J\/OL]. J Neuroimmunol. 2002;127(1\u20132):69\u201379. https:\/\/doi.org\/10.1016\/s0165-5728(02)00098-x.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"2369_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/jlb.42.5.519","volume":"42","author":"B Wierusz-Wysocka","year":"1987","unstructured":"Wierusz-Wysocka B, Wysocki H, Siekierka H, et al. Evidence of polymorphonuclear neutrophils (PMN) activation in patients with insulin-dependent diabetes mellitus[J\/OL]. J Leukoc Biol. 1987;42(5):519\u201323. https:\/\/doi.org\/10.1002\/jlb.42.5.519.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"2369_CR45","first-page":"81","volume":"139","author":"S Schr\u00f6der","year":"1991","unstructured":"Schr\u00f6der S, Palinski W, Schmid-Sch\u00f6nbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy[J]. Am J Pathol. 1991;139(1):81\u2013100.","journal-title":"Am J Pathol"},{"issue":"3","key":"2369_CR46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1076\/ceyr.19.3.219.5314","volume":"19","author":"GR Barile","year":"1999","unstructured":"Barile GR, Chang SS, Park LS, et al. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Curr Eye Res. 1999;19(3):219\u201327. https:\/\/doi.org\/10.1076\/ceyr.19.3.219.5314.","journal-title":"Curr Eye Res"},{"issue":"5","key":"2369_CR47","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1167\/iovs.17-22702","volume":"59","author":"RB Nahomi","year":"2018","unstructured":"Nahomi RB, Sampathkumar S, Myers AM, et al. The absence of indoleamine 2,3-dioxygenase inhibits retinal capillary degeneration in diabetic mice. Invest Ophthalmol Vis Sci. 2018;59(5):2042\u201353. https:\/\/doi.org\/10.1167\/iovs.17-22702.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"2369_CR48","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.biocel.2007.01.004","volume":"39","author":"NJC King","year":"2007","unstructured":"King NJC, Thomas SR. Molecules in focus: indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol. 2007;39(12):2167\u201372. https:\/\/doi.org\/10.1016\/j.biocel.2007.01.004.","journal-title":"Int J Biochem Cell Biol"},{"issue":"7","key":"2369_CR49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/BF02539413","volume":"234","author":"HZ Malina","year":"1996","unstructured":"Malina HZ, Martin XD. Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye. Graefes Arch Clin Exp Ophthalmol. 1996;234(7):457\u201362. https:\/\/doi.org\/10.1007\/BF02539413.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"2369_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1161\/ATVBAHA.121.316668","volume":"42","author":"D Liao","year":"2022","unstructured":"Liao D, Sundlov J, Zhu J, et al. Atomic level dissection of the PECAM-1 homophilic binding interface: Implications for endothelial cell barrier function[J\/OL]. Arterioscler Thromb Vasc Biol. 2022;42(2):193\u2013204. https:\/\/doi.org\/10.1161\/ATVBAHA.121.316668.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2369_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12717","volume":"28","author":"RS Eshaq","year":"2021","unstructured":"Eshaq RS, Harris NR. The role of tumor necrosis factor-\u03b1 and interferon-\u03b3 in the hyperglycemia-induced ubiquitination and loss of platelet endothelial cell adhesion molecule-1 in rat retinal endothelial cells. Microcirculation (New York, NY: 1994). 2021;28(7):e12717. https:\/\/doi.org\/10.1111\/micc.12717.","journal-title":"Microcirculation (New York, NY: 1994)"},{"issue":"11","key":"2369_CR52","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1007\/s00125-023-05995-4","volume":"66","author":"S Dharmarajan","year":"2023","unstructured":"Dharmarajan S, Carrillo C, Qi Z, et al. Retinal inflammation in murine models of type 1 and type 2 diabetes with diabetic retinopathy. Diabetologia. 2023;66(11):2170\u201385. https:\/\/doi.org\/10.1007\/s00125-023-05995-4.","journal-title":"Diabetologia"},{"issue":"7","key":"2369_CR53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/jir.2023.0028","volume":"43","author":"M Afarid","year":"2023","unstructured":"Afarid M, Bahari H, Sanie-Jahromi F. In vitro evaluation of apoptosis, inflammation, angiogenesis, and neuroprotection gene expression in retinal pigmented epithelial cell treated with interferon \u03b1-2b. J Interferon Cytokine Res. 2023;43(7):299\u2013306. https:\/\/doi.org\/10.1089\/jir.2023.0028.","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"2369_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/life15020263","volume":"15","author":"DM Tanase","year":"2025","unstructured":"Tanase DM, Valasciuc E, Gosav EM, et al. Enhancing retinal resilience: the neuroprotective promise of BDNF in diabetic retinopathy. Life (Basel). 2025;15(2):263. https:\/\/doi.org\/10.3390\/life15020263.","journal-title":"Life (Basel)"},{"issue":"1","key":"2369_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/cmi.2016.25","volume":"14","author":"KD Mayer-Barber","year":"2017","unstructured":"Mayer-Barber KD, Yan B. Clash of the cytokine titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses. Cell Mol Immunol. 2017;14(1):22\u201335. https:\/\/doi.org\/10.1038\/cmi.2016.25.","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"2369_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166238","volume":"1867","author":"MJ Giblin","year":"2021","unstructured":"Giblin MJ, Smith TE, Winkler G, et al. Nuclear factor of activated T-cells (NFAT) regulation of IL-1\u03b2-induced retinal vascular inflammation. Biochim Biophys Acta Mol Basis Dis. 2021;1867(12):166238. https:\/\/doi.org\/10.1016\/j.bbadis.2021.166238.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2369_CR57","doi-asserted-by":"publisher","unstructured":"Hooks J J, Nagineni C N, Hooper L C, et al. IFN-beta provides immuno-protection in the retina by inhibiting ICAM-1 and CXCL9 in retinal pigment epithelial cells[J\/OL]. J Immunol (Baltimore, Md.: 1950), 2008, 180(6): 3789\u20133796. https:\/\/doi.org\/10.4049\/jimmunol.180.6.3789.","DOI":"10.4049\/jimmunol.180.6.3789"},{"issue":"6","key":"2369_CR58","doi-asserted-by":"publisher","first-page":"C1452","DOI":"10.1152\/ajpcell.00255.2009","volume":"297","author":"R Li","year":"2009","unstructured":"Li R, Maminishkis A, Banzon T, et al. IFN{gamma} regulates retinal pigment epithelial fluid transport[J\/OL]. Am J Physiol Cell Physiol. 2009;297(6):C1452-1465. https:\/\/doi.org\/10.1152\/ajpcell.00255.2009.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2369_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-015-0192-4","volume":"3","author":"M Kocur","year":"2015","unstructured":"Kocur M, Schneider R, Pulm AK, et al. IFN\u03b2 secreted by microglia mediates clearance of myelin debris in CNS autoimmunity. Acta Neuropathol Commun. 2015;3:20. https:\/\/doi.org\/10.1186\/s40478-015-0192-4.","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"2369_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040942","volume":"19","author":"A R\u00fcbsam","year":"2018","unstructured":"R\u00fcbsam A, Parikh S, Fort PE. Role of inflammation in diabetic retinopathy. Int J Mol Sci. 2018;19(4):942. https:\/\/doi.org\/10.3390\/ijms19040942.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2369_CR61","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1073\/pnas.1813562116","volume":"116","author":"TT Ta","year":"2019","unstructured":"Ta TT, Dikmen HO, Schilling S, et al. Priming of microglia with IFN-\u03b3 slows neuronal gamma oscillations in situ. Proc Natl Acad Sci U S A. 2019;116(10):4637\u201342. https:\/\/doi.org\/10.1073\/pnas.1813562116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2369_CR62","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1177\/1352458506070763","volume":"12","author":"J Kawanokuchi","year":"2006","unstructured":"Kawanokuchi J, Mizuno T, Takeuchi H, et al. Production of interferon-gamma by microglia[J\/OL]. Mult Scler. 2006;12(5):558\u201364. https:\/\/doi.org\/10.1177\/1352458506070763.","journal-title":"Mult Scler"},{"issue":"1","key":"2369_CR63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nbd.2005.09.014","volume":"22","author":"H Takeuchi","year":"2006","unstructured":"Takeuchi H, Wang J, Kawanokuchi J, et al. Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis[J\/OL]. Neurobiol Dis. 2006;22(1):33\u20139. https:\/\/doi.org\/10.1016\/j.nbd.2005.09.014.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"2369_CR64","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.mcn.2005.03.005","volume":"29","author":"O Butovsky","year":"2005","unstructured":"Butovsky O, Talpalar AE, Ben-Yaakov K, et al. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective[J\/OL]. Mol Cell Neurosci. 2005;29(3):381\u201393. https:\/\/doi.org\/10.1016\/j.mcn.2005.03.005.","journal-title":"Mol Cell Neurosci"},{"issue":"8","key":"2369_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250307","volume":"53","author":"TRJ Moreau","year":"2023","unstructured":"Moreau TRJ, Bondet V, Rodero MP, et al. Heterogeneity and functions of the 13 IFN-\u03b1 subtypes - lucky for some? Eur J Immunol. 2023;53(8):e2250307. https:\/\/doi.org\/10.1002\/eji.202250307.","journal-title":"Eur J Immunol"},{"key":"2369_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00300","volume":"10","author":"R Othman","year":"2019","unstructured":"Othman R, Vaucher E, Couture R. Bradykinin type 1 receptor \u2013 inducible nitric oxide synthase: a new axis implicated in diabetic retinopathy. Front Pharmacol. 2019;10:300. https:\/\/doi.org\/10.3389\/fphar.2019.00300.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2369_CR67","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.ajpath.2012.11.031","volume":"182","author":"MS Zinkernagel","year":"2013","unstructured":"Zinkernagel MS, Chinnery HR, Ong ML, et al. Interferon \u03b3-dependent migration of microglial cells in the retina after systemic cytomegalovirus infection. Am J Pathol. 2013;182(3):875\u201385. https:\/\/doi.org\/10.1016\/j.ajpath.2012.11.031.","journal-title":"Am J Pathol"},{"key":"2369_CR68","doi-asserted-by":"publisher","unstructured":"Egwuagu C E, Mahdi R M, Chan C C, et al. Expression of interferon-gamma in the lens exacerbates anterior uveitis and induces retinal degenerative changes in transgenic Lewis rats[J\/OL]. Clinical Immunology (Orlando, Fla.), 1999, 91(2): 196\u2013205. https:\/\/doi.org\/10.1006\/clim.1999.4701.","DOI":"10.1006\/clim.1999.4701"},{"issue":"1","key":"2369_CR69","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.brainres.2006.02.051","volume":"1084","author":"A Das","year":"2006","unstructured":"Das A, Garner DP, Del Re AM, et al. Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx. Brain Res. 2006;1084(1):146\u201357. https:\/\/doi.org\/10.1016\/j.brainres.2006.02.051.","journal-title":"Brain Res"},{"issue":"1","key":"2369_CR70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3928\/1542-8877-20040101-05","volume":"35","author":"I Leibovitch","year":"2004","unstructured":"Leibovitch I, Loewenstein A, Alster Y, et al. Interferon alpha-2a for proliferative diabetic retinopathy after complete laser panretinal photocoagulation treatment[J]. Ophthalmic Surgery, Lasers Imaging: The Off J Int Soc Imag Eye. 2004;35(1):16\u201322.","journal-title":"Ophthalmic Surgery, Lasers Imaging: The Off J Int Soc Imag Eye"},{"issue":"1","key":"2369_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-022-00424-x","volume":"8","author":"H Faghihi","year":"2022","unstructured":"Faghihi H, Inanloo B, Mirzaee A, et al. Evaluation of the additive effect of interferon \u03b1 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema. Int J Retina Vitreous. 2022;8(1):74. https:\/\/doi.org\/10.1186\/s40942-022-00424-x.","journal-title":"Int J Retina Vitreous"},{"issue":"1","key":"2369_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00785-z","volume":"30","author":"T Niu","year":"2024","unstructured":"Niu T, Shi X, Liu X, et al. Porous Se@SiO2 nanospheres alleviate diabetic retinopathy by inhibiting excess lipid peroxidation and inflammation. Mol Med. 2024;30(1):24. https:\/\/doi.org\/10.1186\/s10020-024-00785-z.","journal-title":"Mol Med"},{"issue":"7","key":"2369_CR73","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/08820139.2025.2512143","volume":"54","author":"KS Jo","year":"2025","unstructured":"Jo KS, Song JE, Lee Y. Differences in aqueous humor cytokine concentrations according to the presence of posterior subcapsular cataract: a prospective case-control study. Immunol Investig. 2025;54(7):1099\u2013109. https:\/\/doi.org\/10.1080\/08820139.2025.2512143.","journal-title":"Immunol Investig"},{"key":"2369_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-025-00461-1","volume":"15","author":"SSEM Shaban","year":"2025","unstructured":"Shaban SSEM, Safwat HM, Abdelmohymen AM, et al. Quantitative levels of interferon gamma as a biomarker in the aqueous and serum samples of infectious and noninfectious uveitis patients. J Ophthalmic Inflamm Infect. 2025;15:12. https:\/\/doi.org\/10.1186\/s12348-025-00461-1.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2369_CR75","first-page":"431","volume":"18","author":"J Chua","year":"2012","unstructured":"Chua J, Vania M, Cheung CMG, et al. Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes[J]. Mol Vis. 2012;18:431\u20138.","journal-title":"Mol Vis"},{"issue":"9","key":"2369_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093142","volume":"12","author":"C Oribio-Quinto","year":"2023","unstructured":"Oribio-Quinto C, Burgos-Blasco B, P\u00e9rez-Garc\u00eda P, et al. Aqueous humor cytokine profile in primary congenital glaucoma. J Clin Med. 2023;12(9):3142. https:\/\/doi.org\/10.3390\/jcm12093142.","journal-title":"J Clin Med"},{"key":"2369_CR77","first-page":"1425","volume":"17","author":"S Jiang","year":"2011","unstructured":"Jiang S, Liu X, Luo L, et al. Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery[J]. Mol Vis. 2011;17:1425\u201330.","journal-title":"Mol Vis"},{"issue":"1","key":"2369_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-018-0754-x","volume":"18","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liang Q, Liu Y, et al. Expression of cytokines in aqueous humor from fungal keratitis patients. BMC Ophthalmol. 2018;18(1):105. https:\/\/doi.org\/10.1186\/s12886-018-0754-x.","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"2369_CR79","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s10384-011-0004-8","volume":"55","author":"Y Suzuki","year":"2011","unstructured":"Suzuki Y, Nakazawa M, Suzuki K, et al. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Jpn J Ophthalmol. 2011;55(3):256\u201363. https:\/\/doi.org\/10.1007\/s10384-011-0004-8.","journal-title":"Jpn J Ophthalmol"},{"issue":"7","key":"2369_CR80","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1167\/iovs.11-9244","volume":"53","author":"K Nagata","year":"2012","unstructured":"Nagata K, Maruyama K, Uno K, et al. Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis. Invest Ophthalmol Vis Sci. 2012;53(7):3827\u201333. https:\/\/doi.org\/10.1167\/iovs.11-9244.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"2369_CR81","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1167\/iovs.11-8719","volume":"53","author":"Y Usui","year":"2012","unstructured":"Usui Y, Wakabayashi Y, Okunuki Y, et al. Immune mediators in vitreous fluids from patients with vitreoretinal B-cell lymphoma. Invest Ophthalmol Vis Sci. 2012;53(9):5395\u2013402. https:\/\/doi.org\/10.1167\/iovs.11-8719.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2369_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155308","volume":"137","author":"Q Wei","year":"2021","unstructured":"Wei Q, Zhuang X, Fan J, et al. Proinflammatory and angiogenesis-related cytokines in vitreous samples of highly myopic patients. Cytokine. 2021;137:155308. https:\/\/doi.org\/10.1016\/j.cyto.2020.155308.","journal-title":"Cytokine"},{"issue":"1","key":"2369_CR83","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1159\/000540295","volume":"67","author":"N Su","year":"2024","unstructured":"Su N, Jiang L, Wang Y, et al. Expressions of type I-III interferons in Sj\u00f6gren\u2019s syndrome and non-Sj\u00f6gren\u2019s dry eye. Ophthalmic Res. 2024;67(1):470\u20137. https:\/\/doi.org\/10.1159\/000540295.","journal-title":"Ophthalmic Res"},{"issue":"2","key":"2369_CR84","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","volume":"156","author":"SY Lee","year":"2013","unstructured":"Lee SY, Han SJ, Nam SM, et al. Analysis of tear cytokines and clinical correlations in Sj\u00f6gren syndrome dry eye patients and non-Sj\u00f6gren syndrome dry eye patients. Am J Ophthalmol. 2013;156(2):247-253.e1. https:\/\/doi.org\/10.1016\/j.ajo.2013.04.003.","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"2369_CR85","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","volume":"28","author":"ML Massingale","year":"2009","unstructured":"Massingale ML, Li X, Vallabhajosyula M, et al. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28(9):1023\u20137. https:\/\/doi.org\/10.1097\/ICO.0b013e3181a16578.","journal-title":"Cornea"},{"issue":"2","key":"2369_CR86","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/jir.2006.26.71","volume":"26","author":"M Mrugacz","year":"2006","unstructured":"Mrugacz M, Kaczmarski M, Bakunowicz-Lazarczyk A, et al. IL-8 and IFN-gamma in tear fluid of patients with cystic fibrosis[J\/OL]. J Interferon Cytokine Res: The Off J Int Soc Interferon Cytokine Res. 2006;26(2):71\u20135. https:\/\/doi.org\/10.1089\/jir.2006.26.71.","journal-title":"J Interferon Cytokine Res: The Off J Int Soc Interferon Cytokine Res"},{"issue":"4","key":"2369_CR87","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.4103\/IJO.IJO_2842_22","volume":"71","author":"T Panigrahi","year":"2023","unstructured":"Panigrahi T, D\u2019Souza S, Suresh Babu V, et al. Type 1-type 2 interferon imbalance in dry eye disease. Indian J Ophthalmol. 2023;71(4):1526\u201332. https:\/\/doi.org\/10.4103\/IJO.IJO_2842_22.","journal-title":"Indian J Ophthalmol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02369-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02369-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02369-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:16:03Z","timestamp":1790583363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02369-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2369"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02369-5","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that artificial intelligence (AI) tools were used during the preparation of this manuscript solely for language editing and translation purposes. AI-assisted technologies were applied to improve the clarity, grammar, and readability of the text. As this work is a review article, all literature selection, interpretation, synthesis of evidence, and development of scientific perspectives were performed independently by the authors. No AI tools were used in the generation of scientific content, analysis, or conclusions. The authors take full responsibility for the content of this manuscript.","order":2,"name":"Ethics","label":"Generative AI statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"226"}}